Objectives of the Study:
# To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region.
# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges).
# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall organ preservation market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players.
# To estimate the market size and growth potential of the market segments with respect to five key regions-North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
# To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies.
# To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market.
# To benchmark players in the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering.
Growth Boosting Factors:
The primary factors propelling the growth of this market are the aging population, the number of organ transplants and organ donors, the growing number of cases of multi-organ failure, and the expanding organ donation campaigns.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915
Market Size Estimation:
This study’s market size estimates and forecasts are the result of combining a top-down (evaluation of utilization/adoption/penetration trends by solution, technique, organ type, end user, and region) and bottom-up (segmental analysis of major segments) methodology.
Projected Growth in Revenue Growth:
The global organ preservation market in terms of revenue was estimated to be worth $230 million in 2021 and is poised to reach $317 million by 2026, growing at a CAGR of 6.6% from 2021 to 2026.
Data Triangulation:
The entire market was split up into a number of segments and subsegments after the market size was determined. In order to finalize the market engineering process and obtain precise statistics for every segment and subsegment, data triangulation and market breakdown techniques were utilized, as appropriate.
End User:
The organ transplant centers segment accounted for the largest share of the organ preservation market in 2020
The organ preservation market is divided into organ transplant centers, hospitals, and specialty clinics based on the end user. By 2020, the organ preservation market was dominated by the organ transplant centers segment. The substantial portion of this market can be ascribed to the abundance of hospitals offering organ transplantation services to patients through their transplant programs.
Geographical Growth Dynamics:
Asia-Pacific is expected to register the highest CAGR in the organ preservation market
From 2021 to 2026, the Asia-Pacific market is anticipated to expand at the fastest rate. This can be ascribed to things like the government’s encouraging initiatives, people’s growing awareness, and an increase in organ donations. The rising healthcare infrastructures in China and Japan, the growing medical tourism industry in the RoAPAC countries, the growing prevalence of chronic diseases, and the government regulations that apply to transplantation and related organ donation procedures are all factors that will propel market growth in the APAC region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915
Global Leading Companies:
The prominent players in the global organ preservation market are Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions, Inc. (US), and TX Innovations (Netherlands).
Recent Developments:
# In 2021, Paragonix Technologies launched the LIVERguard Donor Liver Preservation System in both the US and Europe. This strategy expanded Paragonixs’ product offerings and strengthened their geographic presence.
# In 2021, XVIVO Perfusion partnered with Contatti Medical (Brazil) to expand its business and gain access to a comprehensive network of transplantation centers in Latin America’s largest country, Brazil.
# In 2021, Institut Georges Lopez (Igl) (France) expanded its presence by setting up a manufacturing facility in Cheyyar, Tamil Nadu, India, for manufacturing medical devices and solutions for flushing and preservation of organs.
# In 2021, Transmedics received premarket approval from the FDA for the OCS Heart System to be used with organs from donors after brain death (DBD).
# In 2020, Dr. Franz Köhler Chemie GmbH (Germany) entered into a joint venture with Melchers Group and CICEL (Germany) to establish Köhler Pharmaceuticals (Beijing) Ltd. in China for the distribution of Custodiol HTK solutions for cardiac and transplant surgery in the Chinese market.
Inquiry Before Buying@
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=261269915
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
